Understanding immune cell behavior in brain cancer patients

Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials

['FUNDING_P01'] · BRIGHAM AND WOMEN'S HOSPITAL · NIH-10876411

This study is looking at how certain immune cells called T cells work in people with glioblastoma, a type of brain cancer, to find out which genes might be stopping the immune system from fighting the tumors, with the hope of improving cancer treatments for patients in a clinical trial.

Quick facts

Phase['FUNDING_P01']
Study typeNih_funding
SexAll
SponsorBRIGHAM AND WOMEN'S HOSPITAL (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-10876411 on ClinicalTrials.gov

What this research studies

This research investigates how certain immune cells, specifically T cells, function in patients with glioblastoma (GBM), a type of brain cancer. By analyzing genetic data from these T cells, the researchers aim to identify specific genes that may inhibit the immune response against tumors. The study will focus on patients enrolled in a clinical trial receiving a specific treatment, examining how these immune cells interact with tumor cells. The goal is to uncover mechanisms that could enhance the effectiveness of cancer therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are participating in clinical trials.

Not a fit: Patients with other types of cancer or those not enrolled in relevant clinical trials may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer treatments by enhancing the immune response against glioblastoma.

How similar studies have performed: Previous research has shown promising results in enhancing immune responses in cancer through similar approaches, indicating potential for success in this study.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.